Stratification of the immunotypes of tongue squamous cell carcinoma to improve prognosis and the response to immune checkpoint inhibitors

Yuya Su, Ryo Ouchi, Pissacha Daroonpan, Miwako Hamagaki, Tohru Ikeda, Noji Rika, Naoto Nishii, Fumihiko Tsushima, Yoshihito Kano, Takahiro Asakage, Makoto Noguchi, Hiroyuki Harada, Miyuki Azuma

Open source

DOI
10.1007/s00262-025-03982-9
Published
2025-03-01
Container
Cancer Immunology, Immunotherapy
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00262-025-03982-9,
  title = {Stratification of the immunotypes of tongue squamous cell carcinoma to improve prognosis and the response to immune checkpoint inhibitors},
  author = {Yuya Su and Ryo Ouchi and Pissacha Daroonpan and Miwako Hamagaki and Tohru Ikeda and Noji Rika and Naoto Nishii and Fumihiko Tsushima and Yoshihito Kano and Takahiro Asakage and Makoto Noguchi and Hiroyuki Harada and Miyuki Azuma},
  year = {2025},
  journal = {Cancer Immunology, Immunotherapy},
  doi = {10.1007/s00262-025-03982-9},
  url = {https://doi.org/10.1007/s00262-025-03982-9}
}

RIS

TY  - JOUR
TI  - Stratification of the immunotypes of tongue squamous cell carcinoma to improve prognosis and the response to immune checkpoint inhibitors
AU  - Yuya Su
AU  - Ryo Ouchi
AU  - Pissacha Daroonpan
AU  - Miwako Hamagaki
AU  - Tohru Ikeda
AU  - Noji Rika
AU  - Naoto Nishii
AU  - Fumihiko Tsushima
AU  - Yoshihito Kano
AU  - Takahiro Asakage
AU  - Makoto Noguchi
AU  - Hiroyuki Harada
AU  - Miyuki Azuma
PY  - 2025
JO  - Cancer Immunology, Immunotherapy
DO  - 10.1007/s00262-025-03982-9
UR  - https://doi.org/10.1007/s00262-025-03982-9
ER  - 

APA

Su, Y., Ouchi, R., Daroonpan, P., Hamagaki, M., Ikeda, T., Rika, N., Nishii, N., Tsushima, F., Kano, Y., Asakage, T., Noguchi, M., Harada, H., & Azuma, M. (2025). Stratification of the immunotypes of tongue squamous cell carcinoma to improve prognosis and the response to immune checkpoint inhibitors. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-025-03982-9

Source records